ロード中...
The Safety of Peanut Oral Immunotherapy in Peanut Allergic Subjects in a Single-Center Trial
BACKGROUND: Peanut allergy is the leading cause of food-related anaphylaxis and accidental exposures are common. Oral immunotherapy has been posited as a potential treatment. METHODS: Patients ages 3–65 with peanut-specific IgE ≥ 7 kU/L and/or a positive skin prick test with a history of an allergic...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3505766/ https://ncbi.nlm.nih.gov/pubmed/22678151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000336391 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|